Ageing and urogenital symptoms

Author(s):  
Natalia Price ◽  
Simon Jackson
Keyword(s):  
Author(s):  
Ryanne Coulson ◽  
Nalini Rao ◽  
Mark Freeman
Keyword(s):  

2021 ◽  
Vol 22 (6) ◽  
pp. 3212 ◽  
Author(s):  
Li-Ru Chen ◽  
Kuo-Hu Chen

Based on their nutrient composition, soybeans and related foods have been considered to be nutritious and healthy for humans. Particularly, the biological activity and subsequent benefits of soy products may be associated with the presence of isoflavone in soybeans. As an alternative treatment for menopause-related symptoms, isoflavone has gained much popularity for postmenopausal women who have concerns related to undergoing hormone replacement therapy. However, current research has still not reached a consensus on the effects of isoflavone on humans. This overview is a summary of the current literature about the processing of soybeans and isoflavone types (daidzein, genistein, and S-equol) and supplements and their extraction and analysis as well as information about the utilization of isoflavones in soybeans. The processes of preparation (cleaning, drying, crushing and dehulling) and extraction of soybeans are implemented to produce refined soy oil, soy lecithin, free fatty acids, glycerol and soybean meal. The remaining components consist of inorganic constituents (minerals) and the minor components of biologically interesting small molecules. Regarding the preventive effects on diseases or cancers, a higher intake of isoflavones is associated with a moderately lower risk of developing coronary heart disease. It may also reduce the risks of breast and colorectal cancer as well as the incidence of breast cancer recurrence. Consumption of isoflavones or soy foods is associated with reduced risks of endometrial and bladder cancer. Regarding the therapeutic effects on menopausal syndrome or other diseases, isoflavones have been found to alleviate vasomotor syndromes even after considering placebo effects, reduce bone loss in the spine and ameliorate hypertension and in vitro glycemic control. They may also alleviate depressive symptoms during pregnancy. On the other hand, isoflavones have not shown definitive effects regarding improving cognition and urogenital symptoms. Because of lacking standardization in the study designs, such as the ingredients and doses of isoflavones and the durations and outcomes of trials, it currently remains difficult to draw overall conclusions for all aspects of isoflavones. These limitations warrant further investigations of isoflavone use for women’s health.


Urology ◽  
1996 ◽  
Vol 48 (5) ◽  
pp. 715-722 ◽  
Author(s):  
John N. Krieger ◽  
Kelly J. Egan ◽  
Susan O. Ross ◽  
Roberta Jacobs ◽  
Richard E. Berger

2018 ◽  
Vol 29 (12) ◽  
pp. 1807-1815 ◽  
Author(s):  
Lara Stockil ◽  
Judith Thompson ◽  
Kathy Briffa ◽  
Anne Smith ◽  
Darren Beales ◽  
...  

Author(s):  
Muharam R ◽  
Muhammad Ikhsan ◽  
Herdinda Erudite Rizkinya

Objective: The objective of this study was to assess the association between menarche age and menopausal symptoms.Methods: A cross-sectional study with 100 perimenopause subjects. Every subject was assessed of their menopausal symptoms with validated menopause rating scale (MRS) questionnaire. Menopause symptoms were classified into somato-vegetative, psychological, and urogenital symptoms. Statistical analysis was used to assess menarche age and menopause symptoms associations.Results: Out of 100 subjects, somato-vegetative, psychological, and urogenital symptoms were found in 46%, 68%, and 74% cases, respectively. Menarche age was varied between 10 and 17-year-old. There was a significant correlation between menarche age and psychological symptoms (p=0.034). However, there was no significant correlation between menarche age and somato-vegetative as well as urogenital symptoms (p=0.257; p=0.093).Conclusion: There was a significant association between menarche age and psychological symptoms in perimenopause women. However, there was no association between menarche age and somato-vegetative as well as urogenital symptoms in perimenopause women.


2011 ◽  
Vol 25 (1) ◽  
pp. 13
Author(s):  
Nisarath Soontrapa ◽  
Sukree Soontrapa ◽  
Srinaree Kaewrudee ◽  
Woraluk Somboonporn ◽  
Chuanchom Sakondhavat

<em>Objectives</em>. To determine the prevalence of urogenital symptoms (vaginal dryness, dyspareunia, urinary incontinence) and assess patient’s consultation rate and desire for treatment. <em>Design and Methods.</em> This study was prospective descriptive study, performed with the participation of 125 women who presented in menopausal clinic, Srinagarind Hospital. Women completed the questionnaire including questions about their demographic properties and were interviewed by pre-validated questionnaire and in-depth interview to determine the prevalence of urogenital symptoms, consultation rate and patient’s desire for treatment. <em>Results</em>. The mean age of the participants was 57.1 years. Vaginal dryness was found to be the most common postmenopausal urogenital symptoms (71.2%), followed by urinary incontinence (62.4%) and dyspareunia (52.0%). The consultation rates were 62.2% in vaginal dryness, 46.2% in dyspareunia and 38.5% in urinary incontinence. Patient’s desire for treatment was 66.7% in vaginal dryness, 62.1% in dyspareunia and 53.8% in urinary incontinence. <em>Conclusions</em>. Urogenital symptoms are highly prevalent. Physicians need to improve patient-physician communication and increase their attention to these symptoms and their patient’s attitudes to improve patient’s quality of life.


PEDIATRICS ◽  
2008 ◽  
Vol 122 (2) ◽  
pp. e281-e286 ◽  
Author(s):  
C. DeLago ◽  
E. Deblinger ◽  
C. Schroeder ◽  
M. A. Finkel

2010 ◽  
Vol 183 (4S) ◽  
Author(s):  
Giulia Calenda ◽  
Nirmala Kanika ◽  
Sylvia Suadicani ◽  
Moses Tar ◽  
Dwaraka Kuppam ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document